Glenmark Pharmaceuticals: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby confirm that we have uploaded audio recording of Q3 FY 2025-26 Earnings Call held on 02nd February 2026 on the website of the Company.